Literature DB >> 30614355

The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma.

Takuya Maeda1, Koji Yoshino1, Kojiro Nagai1, Satoe Oaku1, Megumi Kato1, Azusa Hiura1, Hiroo Hata2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30614355     DOI： 10.1080/0284186X.2018.1541252

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series.

Authors:  Elizabeth M Gaughan; Bethany J Horton
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

2.  ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation.

Authors:  María Victoria Castro; Gastón Alexis Barbero; Paula Máscolo; Rocío Ramos; María Josefina Quezada; Pablo Lopez-Bergami
Journal:  Cell Mol Biol Lett       Date:  2022-03-08       Impact factor: 5.787

3.  Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients.

Authors:  Mélanie Saint-Jean; Clémentine Fronteau; Lucie Peuvrel; Amir Khammari; Emilie Varey; Gaëlle Quéreux; Brigitte Dréno
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

4.  Long non-coding RNA terminal differentiation-induced non-coding RNA regulates cisplatin resistance of choroidal melanoma by positively modulating extracellular signal-regulated kinase 2 via sponging microRNA-19b-3p.

Authors:  Wei Li; Aiqin Nie; Longyu Jin; Yubo Cui; Ning Xie; Gaohua Liang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.